Nhau
Kurapa Majini Matsva Kwabudirira Mukurapa Chirwere CheSickle Cell neThalassemia
Munyaya yekutanga yekiriniki, murwere ane makore makumi maviri nerimwe ekuberekwa akakunda matambudziko ethalassemia kuburikidza nekurapa kwemajini kwakavakirwa paCRISPR. Iyi nzira itsva inoratidza danho guru mukurapa zvirwere zvakakomba zveropa zvakaita sechirwere chesickle cell (SCD) nethalassemia.
ASH 2024: Chikwata cheLu Daopei Chinoratidza Zviitiko gumi nezvitatu zveKutsvagurudza muHematology
Pamusangano weASH 2024 uri kuuya, timu yekurapa yeLu Daopei Hospital icharatidza zvakawanikwa zvitsvakurudzo gumi nezvitatu zvitsvakurudzo, zvichiratidza kufambira mberi mukurapa kweropa uye mukana wekurapa kweCAR-T, vachisimbisazve kuzvipira kwavo mukuvandudza mhedzisiro yevarwere.
Kukunda Lymphoma neDual CAR-T Therapy
Mushure mekurwara nechirwere chelymphoma kwemakore matatu, mukadzi ane makore makumi matanhatu nerimwe ekuberekwa akawana zororo rakazara kuburikidza nekurapa kweCAR-T kaviri paBIOOCUS, zvichiratidza mukana wekurapa kenza nenzira yepamusoro kuchinja hupenyu.
Kuchinja Kugadziriswa kweMajini: Kufambira Mberi muCRISPR/Cas Technology muBiomedical Applications
Kufambira mberi munguva pfupi yapfuura muhunyanzvi hweCRISPR/Cas kuri kuchinja mamiriro ekugadzirisa majini muongororo yezvekurapa. Chinyorwa chino chinoongorora mashandisirwo azvo, chichiratidza mukana wakakosha wekurapa zvirwere zvemajini, kenza, nezvirwere zvinotapukira.
Rendi Itsva paHupenyu: Kurapa kweCD7 CAR-T kwakabudirira kwava pedyo nekuisa mwana mudumbu ane makore gumi nemashanu ekuberekwa neT-ALL yakadzoka mumuviri
Nyaya inoshamisa paBIOOCUS inoratidza simba rekurapa kweCD7 CAR-T mumukomana ane makore gumi nemashanu ekuberekwa ane T-cell acute lymphoblastic leukemia (T-ALL) yakadzoka, zvichikonzera kurerukirwa kwakakwana uye kuisirwa kwechipiri kwakabudirira.
Bioocus Inobatanidzwa muIGC 2024 kuti Iongorore Kubatana Kutsva uye MaModheru Ebhizinesi muImmuno-Gene uye Cell Therapy
Bioocus inofara kupinda mumusangano wechisere weImmuno-Gene and Cell Therapy Congress (IGC 2024)! Tinotarisira kushanda pamwe chete nenyanzvi dzepasi rose uye kutsvaga mabhizinesi matsva anoenderana netekinoroji yekurapa majini nemasero. Pamwe chete, ngatigadzirei ramangwana rekurapa immunotherapy.
Kugadzirisa Migumisiro Yekurapa Masero eCAR-T: Pfungwa Huru Kubva Mukutsvagurudza Kwazvino
Nyaya iyi yenhau inoratidza tsvakiridzo yazvino pamusoro pekugadzirisa chepfu dziri muCAR-T cell therapy yeB-cell lymphomas. Chidzidzo ichi chinosimbisa nzira dzekugadzirisa migumisiro yakafanana necytokine release syndrome (CRS) uye neurotoxicity (ICANS), zvichiita kuti kurapwa uku kuve kwakachengeteka.
Kushanda Kwakanyanya kweCD7 CAR-T Therapy yeB-Cell Malignancies: Kubudirira Mukurapa Kenza
Ongororo yazvino inoratidza kushanda uye kuchengetedzeka kweCD7 CAR-T cell therapy mukurapa B-cell acute lymphoblastic leukemia (B-ALL) yakadzoka kana kuti isingadzoreki uye T-cell lymphoblastic lymphoma (T-LBL). Chidzidzo ichi chakaitwa neBIOOCUS pamwe chete neLu Daopei Hospital, chinoratidza mhedzisiro inovimbisa kuvarwere, ichipa imwe nzira ine simba pane chemotherapy yechinyakare.
Tariro Itsva yeChemotherapy-Refractory B-Cell Lymphoma: Kurapa kweCAR-T Kunoratidza Mhedzisiro Inofadza
Chidzidzo ichi, chakaburitswa mu Chinyorwa cheClinical Oncology, inoratidza mwero mukuru wekuregererwa kwevarwere vakange vapedza nzira dzekurapa dzechinyakare, zvichiratidza kufambira mberi kwakanaka mukurapa kenza.
Mhedzisiro Inovimbisa yeKurapwa kweCD7 CAR-T Yakasanganiswa neKuisirwa Kwechipiri muVarwere Vakadzokera muT-ALL/LBL
Ongororo ichangobva kuitwa inoratidza kushanda kwekurapa kweCD7 CAR-T kunoteverwa nekuwedzera kwechipiri allogeneic hematopoietic stem cell transplantation (HSCT) muvarwere vane relapsely T-cell acute lymphoblastic leukemia (T-ALL) uye lymphoblastic lymphoma (LBL), zvichiratidza mukana mukuru wekuwana minimal residual disease (MRD)-negative complete relieval.
Kushanda Kwenguva Refu KweCD19 CAR T-Cell Therapy Mukurapa Relapsed/Refractory Acute Lymphoblastic Leukemia
Ongororo itsva inoratidza kubudirira kwenguva refu kwekurapa kweCD19 CAR T-cell mukurapa varwere vane relapse/refractory acute lymphoblastic leukemia (ALL) mushure mekuisirwa allogeneic hematopoietic stem cell transplantation, zvichipa tariro itsva mu hematology.
Bioocus Inofambira Mberi Mukurapa Vana Vane Acute Lymphoblastic Leukemia
Bioocus iri pamberi mukugadzira mishonga yeCAR-T yechizvarwa chinotevera. Chinyorwa chitsva chaDr. Chunrong Tong nechikwata chake kuLu Daopei Hospital chinoratidza kufambira mberi kwakakosha nematambudziko mukushandiswa kwemishonga yeCD19 CAR-T yechizvarwa chechipiri muvarwere vevana, zvichiratidza kuzvipira kwaBioocus mukurapa kenza nenzira itsva.